Page 107 - pathology_services_handbook_5th_edition_2018
P. 107

No.  Test  Unit  Type of Specimen  Form  Container/Preservatives  Sample Volume  Referral Lab  TAT  Remark
 Primary Immunodeficiency Screening:
 a. Lymphocyte subsets (TBNK)
               EDTA            2 ML          IMR     14 working days  By appointment
 Download                                                           (ext: 2782)
  342.   b. Immunoglobulin and Complement  from IMR   serum  2 ML  IMR  14 working days
 Serology  Blood  website
 c. LAD        EDTA            2 ML          IMR     14 working days            LIST OF TESTS
                                                                   Need control
 d. DHR     Lithium Heparin    2 ML          IMR     14 working days
                                                                     blood
                                          Hospital Am-
 343.  Protein Electrophoresis, serum  Chem. Patho.  Blood  PER-PAT 301  Plain tube  3.5 ml  pang (Chemical   30 working days
                                           Pathology)
 Urine                                                             Urine sample must
 (preferably early   PER-PAT 301  Sterile container  20 ml  Hospital Am-  be paired with serum
 344.  Protein Electrophoresis, urine   Chem. Patho.  morning)  pang (Chemical   30 working days  sample
                                           Pathology)
 Blood  PER-PAT 301  Plain tube  3.5 ml
                                             HKL
 345.  Prostate Specific Antigen, Free  Chem. Patho.  Blood  PER-PAT 301  Plain tube  3 ml  (Clinical Toxicol-  2 working days
                                             ogy)
                                             IMR
 IMR/UMDP/                 2 EDTA tubes (2 ml   (Molecular        Please refer page
 346.  Pseudorheumatoid Dysplasia (WISP3)  Chem. Patho.  Blood  EDTA tube  30 working days
 02                         for each tube)  Diagnostic &            178 No. 4.6
                                           Protein)
                                             IMR
 IMR/UMDP/                 2 EDTA tubes (2 ml   (Molecular        Please refer page
 347.  PTEN-associated Diseases (PTEN)  Chem. Patho.  Blood  EDTA tube  30 working days
 02                         for each tube)  Diagnostic &            178 No. 4.6
                                           Protein)
          Special microtube with
 IMR/SDC/ BC/  preservative EDTA and     IMR (Biochem-             Protect from
 348.  Pterins, CSF  Chem. Patho.  CSF  0.5 ml       15 working days
 FORM-RQ  DTE (provided by Bio-             istry)                    light
          chemistry Unit, IMR)
 IMR/SDC/ BC/                            IMR (Biochem-             Protect from
 349.  Pterins, urine (Screening)  Chem. Patho.  Random urine  Sterile container  2 ml  15 working days
 FORM-RQ                                    istry)                    light
                                             HKL
 350.  Purine and Pyrimidine, urine  Chem. Patho.  Random urine  PER-PAT 301  Sterile container  2 ml
                                            (IEM)
                                             IMR
 Purine Nucleoside Phosphorylase   IMR/UMDP/   2 EDTA tubes (2 ml   (Molecular   Please refer page
 351.  Chem. Patho.  Blood  EDTA tube                30 working days
 Deficiency (PNP)  02       for each tube)  Diagnostic &            178 No. 4.6
                                           Protein)









                                                                        97
   102   103   104   105   106   107   108   109   110   111   112